SecBot SecBot
SECBOTREPLAY Home › Report › NRIX

NRIX · Fidelity stake drops to 4.2%

Nurix Therapeutics, Inc. · SC 13G/A filed Nov 5, 2026 at 13:22 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 5, 2026 at 13:22 ET

FMR LLC (Fidelity) filed an amended Schedule 13G disclosing a 4.2% passive stake in Nurix Therapeutics as of September 30, 2026, down from a prior position. The filing confirms Fidelity remains a significant passive holder but below the 5% threshold, with no intent to influence control.

  • FMR LLC reported beneficial ownership of 4,350,596.42 shares of Nurix Therapeutics common stock as of September 30, 2026.
  • The stake represents 4.2% of shares outstanding, below the 5% threshold.
  • This is an amendment to a prior Schedule 13G filing, indicating a decrease from a previously larger position.
  • FMR LLC certifies the shares were acquired and are held in the ordinary course of business with no intent to influence control.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access